Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bicara Therapeutics Inc. Common Stock
Market Cap
$1.14B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$1.14B
Operating Margin
14.18%
TTM Avg
9.30%
3Y Avg
5.28%
5Y Avg
4.02%
Market Cap
$1.12B
Operating Margin
-8.99%
TTM Avg
-4.92%
3Y Avg
-23.48%
5Y Avg
-24.49%
Market Cap
$1.12B
Operating Margin
15.66%
TTM Avg
23.78%
3Y Avg
24.92%
5Y Avg
19.79%
Market Cap
$1.16B
Operating Margin
10.25%
TTM Avg
9.64%
3Y Avg
3.98%
5Y Avg
-5.39%
Market Cap
$1.11B
Operating Margin
31.92%
TTM Avg
30.59%
3Y Avg
30.27%
5Y Avg
23.69%
Market Cap
$1.20B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.21B
Operating Margin
-11.96%
TTM Avg
-38.52%
3Y Avg
-75.67%
5Y Avg
-204.09%
Market Cap
$1.05B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. Common Stock (BCAX) | $1.14B | 0.00% | 0.00% | 0.00% | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 14.18% | 9.30% | 5.28% | 4.02% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -8.99% | -4.92% | -23.48% | -24.49% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 15.66% | 23.78% | 24.92% | 19.79% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 10.25% | 9.64% | 3.98% | -5.39% |
| IRadimed Corporation (IRMD)vs › | $1.11B | 31.92% | 30.59% | 30.27% | 23.69% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | 0.00% | 0.00% | 0.00% | 0.00% |
| Cronos Group Inc. (CRON)vs › | $1.21B | -11.96% | -38.52% | -75.67% | -204.09% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -6.98% | -25.06% | -156.73% | -114.38% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 6.39% | 1.60% | -1.75% | 0.68% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
